| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 76 |
| 1 | QUETIAPINE | 66 |
| 2 | VENLAFAXINE HYDROCHLORIDE | 57 |
| 3 | DIAZEPAM | 54 |
| 4 | OXYCODONE HYDROCHLORIDE | 54 |
| 5 | VENLAFAXINE | 51 |
| 6 | DIAZEPAM ORAL | 50 |
| 7 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 50 |
| 8 | FLUOXETINE HYDROCHLORIDE | 48 |
| 9 | METHYLPHENIDATE HYDROCHLORIDE | 46 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 1 | ZIPRASIDONE | 14 | 0.0039 |
| 2 | AMISULPRIDE | 18 | 0.0029 |
| 3 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 12 | 0.0023 |
| 4 | BREXPIPRAZOLE | 24 | 0.0014 |
| 5 | CARIPRAZINE | 13 | 0.0013 |
| 6 | ASENAPINE MALEATE | 10 | 0.0012 |
| 7 | PAROXETINE HYDROCHLORIDE | 38 | 0.0009 |
| 8 | GEMFIBROZIL | 10 | 0.0009 |
| 9 | LISDEXAMFETAMINE DIMESYLATE | 27 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 145 |
| 1 | Atypical Antipsychotic [EPC] | 137 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 33 |
| 4 | Corticosteroid [EPC] | 31 |
| 5 | Provitamin D2 Compound [EPC] | 20 |
| 6 | Vitamin C [EPC] | 20 |
| 7 | Anti-epileptic Agent [EPC] | 19 |
| 8 | Opioid Agonist [EPC] | 19 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 18 | 0.0023 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 4 | 0.0010 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 33 | 0.0003 |
| 6 | Atypical Antipsychotic [EPC] | 137 | 0.0003 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 14 | 0.0002 |
| 8 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 7 | 0.0002 |